3 - ( 4 - Methoxyphenyl ) - fervenulin | 52199-07-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3 - ( 4 - Methoxyphenyl ) - fervenulin
• 英文别名: 3-(p-Anisyl)fervenulin；3-(4-methoxyphenyl)-6,8-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(6H,8H)-dione；3-(4-methoxyphenyl)-6,8-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione
• CAS: 52199-07-2
• 化学式: C₁₄H₁₃N₅O₃
• mdl: MFCD00407393
• 分子量: 299.289
• InChiKey: HLHXWPNCUXQIKX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  88.5
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3 - ( 4 - Methoxyphenyl ) - fervenulin 在 三溴化硼 、 caesium carbonate 作用下， 以 二氯甲烷 、 丙酮 为溶剂， 生成 3-(4-(2-(diethylamino)ethoxy)phenyl)-6,8-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(6H,8H)-dione
  参考文献：
  名称：

  Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription

  摘要：

  Nearly all colorectal cancers (CRCs) and varied subsets of other cancers have somatic mutations leading to beta-catenin stabilization and increased beta-catenin/TCF transcriptional activity. Inhibition of stabilized beta-catenin in CRC cell lines arrests their growth and highlights the potential of this mechanism for novel cancer therapeutics. We have pursued efforts to develop small molecules that inhibit beta-catenin/TCF transcriptional activity. We used xanthothricin, a known beta-catenin/TCF antagonist of microbial origin, as a lead compound to synthesize related analogues with drug-like features such as low molecular weight and good metabolic stability. We studied a panel of six candidate Wnt/beta-catenin/Tcf-regulated genes and found that two of them (Axin2, Lgr5) were reproducibly activated (9-10 fold) in rat intestinal epithelial cells (IEC-6) following beta-catenin stabilization by Wnt-3a ligand treatment. Two previously reported beta-catenin/TCF antagonists (calphostin C, xanthothricin) and XAV939 (tankyrase antagonist) inhibited Wnt-activated genes in a dose-dependent fashion. We found that four of our compounds also potently inhibited Wnt-mediated activation in the panel of target genes. We investigated the mechanism of action for one of these (8c) and demonstrated these novel small molecules inhibit beta-catenin transcriptional activity by degrading beta-catenin via a proteasome-dependent, but GSK3 beta-, APC-, AXIN2- and beta TrCP-independent, pathway. The data indicate the compounds act at the level of beta-catenin to inhibit Wnt/beta-catenin/TCF function and highlight a robust strategy for assessing the activity of beta-catenin/TCF antagonists. (c) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.08.111
• 作为产物：
  描述：

  3-甲基-6-(1-甲基肼基)-2,4(1H,3H)-嘧啶二酮 在 caesium carbonate 、 溶剂黄146 、 硫酸二甲酯 、 sodium nitrite 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 31.0h， 生成 3 - ( 4 - Methoxyphenyl ) - fervenulin
  参考文献：
  名称：

  Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription

  摘要：

  Nearly all colorectal cancers (CRCs) and varied subsets of other cancers have somatic mutations leading to beta-catenin stabilization and increased beta-catenin/TCF transcriptional activity. Inhibition of stabilized beta-catenin in CRC cell lines arrests their growth and highlights the potential of this mechanism for novel cancer therapeutics. We have pursued efforts to develop small molecules that inhibit beta-catenin/TCF transcriptional activity. We used xanthothricin, a known beta-catenin/TCF antagonist of microbial origin, as a lead compound to synthesize related analogues with drug-like features such as low molecular weight and good metabolic stability. We studied a panel of six candidate Wnt/beta-catenin/Tcf-regulated genes and found that two of them (Axin2, Lgr5) were reproducibly activated (9-10 fold) in rat intestinal epithelial cells (IEC-6) following beta-catenin stabilization by Wnt-3a ligand treatment. Two previously reported beta-catenin/TCF antagonists (calphostin C, xanthothricin) and XAV939 (tankyrase antagonist) inhibited Wnt-activated genes in a dose-dependent fashion. We found that four of our compounds also potently inhibited Wnt-mediated activation in the panel of target genes. We investigated the mechanism of action for one of these (8c) and demonstrated these novel small molecules inhibit beta-catenin transcriptional activity by degrading beta-catenin via a proteasome-dependent, but GSK3 beta-, APC-, AXIN2- and beta TrCP-independent, pathway. The data indicate the compounds act at the level of beta-catenin to inhibit Wnt/beta-catenin/TCF function and highlight a robust strategy for assessing the activity of beta-catenin/TCF antagonists. (c) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.08.111

文献信息

• Construction of pyrimido[5,4-<i>e</i>]-<i>as</i>-triazine, purine,<i>v</i>-triazolo-[4,5-<i>d</i>]pyrimidine and pyrazolo[3,4-<i>d</i>]pyrimidine ring systems from 5-arylazo-6-arylidenehydrazino-1,3-dimethyluracils
  作者：Sadao Nishigaki、Misuzu Ichiba、Kiyoko Fukami、Keitaro Senga

  DOI：10.1002/jhet.5570190413

  日期：1982.7

  Reaction of 5-arylazo-6-arylidenehydrazino-1,3-dimethyluracils (II), prepared by the treatment of 6-aryl-idenehydrazino-1,3-dimethyluracils (I) with diazotized arylamines, with dimethylformamide dimethylacetal resulted in the formation of pyrimido[5,4-e]-as-triazine (V) system, while the thermolysis of II resulted in the formation of purine (X), v-triazolo[4,5-d]pyrimidine (XII), and pyrazolo[3,4-d]pyrimidine

  通过用重氮化的芳胺处理6-芳基-亚氨基肼基-1,3-二甲基尿嘧啶（I）制备的5-芳基偶氮-6-亚芳基肼基-1,3-二甲基尿嘧啶（II）与二甲基甲酰胺二甲基缩醛反应形成以嘧啶[5,4- e ]-为-三嗪（V）体系，而II的热解导致嘌呤（X），v-三唑并[4,5- d ]嘧啶（XII）和吡唑并[ 3,4- d ]嘧啶（XIV，XIX）系统代替了预期的V。已提出了在这些反应中形成各种环系统的合理机理。
• Kanazawa, Hashime; Nishigaki, Sadao; Senga, Keitaro, Journal of Heterocyclic Chemistry, 1984, vol. 21, p. 969 - 974
  作者：Kanazawa, Hashime、Nishigaki, Sadao、Senga, Keitaro

  DOI：——

  日期：——
• Senga, Keitaro; Nishigaki, Sadao, Heterocycles, 1981, vol. 16, # 4, p. 559 - 561
  作者：Senga, Keitaro、Nishigaki, Sadao

  DOI：——

  日期：——
• Reactions of fervenulin and its 3-substituted analogs with indole
  作者：Yu. A. Azev、I. I. Mudretsova、L. N. Kurkovskaya、A. F. Goleneva、G. A. Aleksandrova

  DOI：10.1007/bf00769651

  日期：1988.5
• KANAZAWA, HASHIME;NISHIGAKI, SADAO;SENGA, KEITARO, J. HETEROCYCL. CHEM., 1984, 21, N 4, 969-974
  作者：KANAZAWA, HASHIME、NISHIGAKI, SADAO、SENGA, KEITARO

  DOI：——

  日期：——